Insider Trading History of Wichterman Troy

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wichterman Troy since 2021. This trader's CIK number is 1892616. At the time of last reporting, Wichterman Troy was the Chief Financial Officer of Biolife Solutions Inc. (stock ticker symbol BLFS). Also see all insider trading activities at Biolife Solutions Inc.



Yearly summary of insider trading at Biolife Solutions Inc (BLFS) by Wichterman Troy

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 BLFS 0 $0 34,626 $799,907 0 $0
2024 BLFS 0 $0 15,494 $284,142 0 $0
2023 BLFS 0 $0 13,991 $273,711 938 $1,932
2022 BLFS 0 $0 3,410 $72,669 0 $0
2021 BLFS 0 $0 343 $13,171 0 $0


Insider trading of Biolife Solutions Inc (BLFS) by Wichterman Troy

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-08-26 BLFS Sale 590 25.44 15,009
2025-07-07 BLFS Sale 877 22.27 19,530
2025-05-28 BLFS Sale 583 22.46 13,094
2025-04-09 BLFS Sale 932 20.11 18,742
2025-04-01 BLFS Sale 25,687 22.66 582,067
2025-03-11 BLFS Sale 4,151 25.00 103,775
2025-03-03 BLFS Sale 660 25.46 16,803
2025-02-12 BLFS Sale 159 26.54 4,219
2025-01-06 BLFS Sale 987 27.02 26,668
2024-11-26 BLFS Sale 581 27.20 15,803
2024-11-12 BLFS Sale 147 26.19 3,849
2024-10-30 BLFS Sale 894 23.15 20,696
2024-07-11 BLFS Sale 828 20.54 17,007
2024-08-21 BLFS Sale 142 25.61 3,636
2024-09-16 BLFS Sale 611 25.12 15,348
2024-05-29 BLFS Sale 574 21.78 12,501
2024-05-17 BLFS Sale 115 22.18 2,550
2024-04-18 BLFS Sale 956 15.31 14,636
2024-03-21 BLFS Sale 520 17.83 9,271
2024-03-11 BLFS Sale 361 17.42 6,288
2024-03-12 BLFS Sale 7,249 16.60 120,333
2024-02-21 BLFS Sale 97 17.35 1,682
2024-01-19 BLFS Sale 2,419 16.76 40,542
2023-12-22 BLFS Sale 314 16.79 5,272
2023-12-01 BLFS Sale 666 12.37 8,238
2023-11-13 BLFS Sale 97 10.66 1,034
2023-09-21 BLFS Sale 539 12.70 6,845
2023-08-25 BLFS Sale 585 10.99 6,429
2023-08-14 BLFS Sale 94 12.57 1,181
2023-06-22 BLFS Sale 541 23.41 12,664
2023-05-31 BLFS Sale 560 23.21 12,997
2023-05-16 BLFS Sale 137 19.41 2,659
2023-03-20 BLFS Option Ex 938 2.06 1,932
2023-03-20 BLFS Sale 10,000 20.64 206,400
2023-03-22 BLFS Sale 310 21.84 6,770
2023-03-07 BLFS Sale 31 22.95 711
2023-02-21 BLFS Sale 117 21.47 2,511
2022-12-22 BLFS Sale 528 17.55 9,266
2022-11-29 BLFS Sale 52 19.93 1,036
2022-11-22 BLFS Sale 121 20.20 2,444
2022-09-23 BLFS Sale 569 21.91 12,466
2022-08-31 BLFS Sale 51 23.44 1,195
2022-08-16 BLFS Sale 116 24.81 2,877
2022-06-24 BLFS Sale 456 15.95 7,273
2022-05-27 BLFS Sale 43 14.53 624
2022-05-13 BLFS Sale 125 12.32 1,540
2022-03-22 BLFS Sale 551 23.06 12,706
2022-03-01 BLFS Sale 56 23.78 1,331
2022-02-15 BLFS Sale 695 26.57 18,466
2022-01-07 BLFS Sale 47 30.75 1,445
2021-12-22 BLFS Sale 310 38.49 11,931
2021-11-30 BLFS Sale 33 37.59 1,240

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wichterman Troy (Chief Financial Officer of Biolife Solutions Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.